Home » Newsletters » BioWorld Science

BioWorld Science

July 11, 2016

View Archived Issues

Valneva develops Zika virus vaccine

Phase III S-TRAC study of sunitinib meets primary endpoint

Design of a novel dimeric compound that targets the pathogenic RNA in spinocerebellar ataxia 10

Results from phase III LUNAR study of LBN 0.024% in open-angle glaucoma or ocular hypertension

Anti-tau antibody enters phase I trials, AC Immune eligible to receive milestone payment

Proteostasis Therapeutics patents CFTR channel correctors

Gilead Sciences obtains European marketing authorization for Epclusa

Evotec collaborates with Antibiotic Research UK to tackle antibiotic resistance

Ligand Pharmaceuticals and Gilead Sciences enter OmniAb agreement

FDA approves use of SurePath Preservative Fluid with cobas HPV Test

Ono Pharmaceutical discloses AXL inhibitors

Nichi-Iko Pharmaceutical to acquire Sagent Pharmaceuticals

Gilead Sciences describes HIV reverse transcriptase inhibitors

Merck & Co. develops orexin OX2 receptor antagonists

LG Life Sciences presents FFAR4 agonists

Multiple doses of intravenous echinocandin CD-101 safe and well tolerated in phase I study

Alios BioPharma announces agents for picornavirus infections

Regulatory submissions planned for niraparib following phase III results

Vernalis completes CCP-08 study

Topline results from pivotal European study of Infacort in pediatric adrenal insufficiency

Ono Pharmaceutical licenses rights to Celyad's NKR-2 in Japan, South Korea and Taiwan

GlyRS shows promise as a therapeutic target for cancer

FDA grants orphan drug designation to ZW-33

Karyopharm's selinexor granted U.S. orphan status for soft tissue sarcoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...